Last reviewed · How we verify
A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin
Comparison between the effectiveness of one anti-diabetic drug (Metformin, To combination of this drug and additional drug (Janufer), In the community setting.
Details
| Lead sponsor | Meir Medical Center |
|---|---|
| Phase | Phase 3 |
| Status | UNKNOWN |
| Enrolment | 1000 |
| Start date | 2008-06 |
| Completion | 2012-12 |
Conditions
- Diabetes Type 2
Interventions
- Metformin 1500 mg daily
- Metformin + Janufer (Janumet)
Primary outcomes
- The efficacy and safety of community based study in diabetic patients, comparing Metformin to Metformin + Janufer. — 54 weeks
- The efficacy and safety of Metformin VS Metformin + Janufer in the community setting — 2010
Countries
Israel